Receptor Activator of Nuclear Factor-kappa B

"Receptor Activator of Nuclear Factor-kappa B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A tumor necrosis factor receptor family member that is specific for RANK LIGAND and plays a role in bone homeostasis by regulating osteoclastogenesis. It is also expressed on DENDRITIC CELLS where it plays a role in regulating dendritic cell survival. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.

Descriptor ID	D053246
MeSH Number(s)	D12.776.543.750.705.852.760.345
Concept/Terms	Receptor Activator of Nuclear Factor-kappa B Receptor Activator of Nuclear Factor-kappa B Receptor Activator of Nuclear Factor kappa B Receptor Activator of NF-kappa B Receptor Activator of NF kappa B TRANCE-R TRANCE R TRANCE Receptor RANK Protein Receptor Activator of NF-kappaB Receptor Activator of NF kappaB NF-KappaB Receptor Activator Activator, NF-KappaB Receptor NF KappaB Receptor Activator Receptor Activator, NF-KappaB Receptors, Tumor Necrosis Factor, Member 11a Receptor Activator of Nuclear Factor-kappaB Receptor Activator of Nuclear Factor kappaB Tumor Necrosis Factor Receptor Superfamily, Member 11a NF-Kappa B Receptor Activator NF Kappa B Receptor Activator CD265 Antigen Antigen, CD265 TNFRSF11A Protein

Below are MeSH descriptors whose meaning is more general than "Receptor Activator of Nuclear Factor-kappa B".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Cytokine [D12.776.543.750.705.852]
Receptors, Tumor Necrosis Factor [D12.776.543.750.705.852.760]
Receptor Activator of Nuclear Factor-kappa B [D12.776.543.750.705.852.760.345]

Below are MeSH descriptors whose meaning is related to "Receptor Activator of Nuclear Factor-kappa B".

Below are MeSH descriptors whose meaning is more specific than "Receptor Activator of Nuclear Factor-kappa B".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptor Activator of Nuclear Factor-kappa B" by people in this website by year, and whether "Receptor Activator of Nuclear Factor-kappa B" was a major or minor topic of these publications.

Bar chart showing 6 publications over 6 distinct years, with a maximum of 1 publications in 2002 and 2003 and 2004 and 2005 and 2009 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2003	0	1	1
2004	0	1	1
2005	0	1	1
2009	0	1	1
2016	1	0	1

Below are the most recent publications written about "Receptor Activator of Nuclear Factor-kappa B" by people in Profiles.

O'Brien W, Fissel BM, Maeda Y, Yan J, Ge X, Gravallese EM, Aliprantis AO, Charles JF. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis. Arthritis Rheumatol. 2016 12; 68(12):2889-2900.

View in: PubMed
Kim SJ, Chen Z, Chamberlain ND, Essani AB, Volin MV, Amin MA, Volkov S, Gravallese EM, Arami S, Swedler W, Lane NE, Mehta A, Sweiss N, Shahrara S. Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis. J Immunol. 2014 Oct 15; 193(8):3902-13.

View in: PubMed
Sun Y, Ishibashi M, Seimon T, Lee M, Sharma SM, Fitzgerald KA, Samokhin AO, Wang Y, Sayers S, Aikawa M, Jerome WG, Ostrowski MC, Bromme D, Libby P, Tabas IA, Welch CL, Tall AR. Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circ Res. 2009 Feb 27; 104(4):455-65.

View in: PubMed
Amcheslavsky A, Bar-Shavit Z. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides. J Cell Physiol. 2006 Apr; 207(1):244-50.

View in: PubMed
Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology (Oxford). 2006 Sep; 45(9):1068-76.

View in: PubMed
Walsh NC, Crotti TN, Goldring SR, Gravallese EM. Rheumatic diseases: the effects of inflammation on bone. Immunol Rev. 2005 Dec; 208:228-51.

View in: PubMed
Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, Yeh WC, Lee SK, Lorenzo JA, Choi Y. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med. 2005 Sep 05; 202(5):589-95.

View in: PubMed
Saltman LH, Javed A, Ribadeneyra J, Hussain S, Young DW, Osdoby P, Amcheslavsky A, van Wijnen AJ, Stein JL, Stein GS, Lian JB, Bar-Shavit Z. Organization of transcriptional regulatory machinery in osteoclast nuclei: compartmentalization of Runx1. J Cell Physiol. 2005 Sep; 204(3):871-80.

View in: PubMed
Amcheslavsky A, Hemmi H, Akira S, Bar-Shavit Z. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis. J Bone Miner Res. 2005 Sep; 20(9):1692-9.

View in: PubMed
Amcheslavsky A, Zou W, Bar-Shavit Z. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis. J Biol Chem. 2004 Dec 24; 279(52):54039-45.

View in: PubMed

People

Explore

Similar Concepts

Top Journals